BASF will move its BASF Plant Science headquarters to Raleigh, North Carolina.
BASF (Ludwigshafen, Germany) says it is shifting its plant biotechnology business towards North and South America because of a lack of acceptance for the technology in much of Europe.
“We are convinced that plant biotechnology is a key technology for the 21st century. However, there is still a lack of acceptance for this technology in many parts of Europe-from the majority of consumers, farmers, and politicians,” said Stefan Marcinowski, PhD, a member of BASF’s board of executive directors.
The company will halt the development and commercialization of GMO products intended solely for European markets, including but not limited to genetically modified starch potatoes (Amflora, Amadea, and Modena) and a wheat variety resistant to fungal disease.
In its transition towards the American markets, BASF will move the headquarters of its subsidiary BASF Plant Science from Limburgerhof, Germany to Raleigh, North Carolina. Some employment positions will be cut, but the company will try to retain employees within BASF Plant Science or different sectors of the company.